DDS Dillard's (DDS) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Retail-department stores · CIK 0000028917
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
177
13F, latest reported quarter
What the filings say about DDS
Insiders, 180 days
-$243.7K net sold
1 seller · 0% of sales under a 10b5-1 plan
Activist stakes (13D), 180 days
1 filing
Largest: 31.8% of the class
Dillard's insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, DILLARD'S, INC. insiders sold a net $243.7K of stock across 21 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Oct 16, 2025.
- The trade is 3.9% of the 10,150 shares held after it.
- No other insider sold within 30 days.
- 177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WATTS J C JR sold about $243.7K of DDS on Jun 5, 2026; 177 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Mar 3, 2025.
- The trade is 7.3% of the 10,250 shares held after it.
- 1 other insider sold within 30 days.
- 177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WATTS J C JR sold about $445.9K of DDS on Oct 16, 2025, the largest insider sale at the company since 2022; 1 other insider sold within 30 days and 177 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Jan 12, 2023.
- The trade is 4.3% of the 9,351 shares held after it.
- 1 other insider sold within 30 days.
- 177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SENIOR VICE PRESIDENT Johnson Chris B. sold about $246.8K of DDS on Sep 29, 2025; 1 other insider sold within 30 days and 177 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jun 7, 2024.
- The trade is 7.5% of the 10,600 shares held after it.
- No other insider sold within 30 days.
- 177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WATTS J C JR sold about $316.0K of DDS on Mar 3, 2025, the largest insider sale at the company since 2024; 177 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 7, 2023.
- The trade is 25.7% of the 1,167 shares held after it.
- No other insider sold within 30 days.
- 177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VICE PRESIDENT BOLIN TOM W sold about $130.0K of DDS on Jan 14, 2025; 177 funds added in the latest 13F quarter.21 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$243.7K over 180 days
more than 62% of Wholesale & Retail
Congress
no House purchase disclosed in the last 12 months
Funds
177 funds bought in last quarter
more than 66% of Wholesale & Retail
Revenue
-0.1% year over year
below 64% of Wholesale & Retail
Margin
8.8% net margin
more than 86% of Wholesale & Retail
Buybacks
$107.8M repurchased, FY to 2026-01-31
more than 63% of Wholesale & Retail
Short interest
12.5% of the float short (float per yahoo 2026-10-26) · 4.5 days to cover · settled 2026-09-30
The situation: each line is one rule over one dataset
William T. Dillard, II disclosed a 5%+ stake (30.0%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch DDS
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+20.0%12M
Insider sell13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns DDS: institutional holders (13F)
13F holdings, latest reported quarter
4,472,875 sh
$2.4B
218,316 sh
$115.4M
214,974 sh
$113.6M
190,636 sh
$100.7M
162,415 sh
$85.8M
Congress trades in DDS
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
William T. Dillard, II
Activist 13D · 2026-06-05
30.0%
Alex Dillard
Activist 13D · 2026-06-05
31.8%
Mike Dillard
Activist 13D · 2026-06-05
27.7%
DDS planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
DDS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
The Acquirers Fund
$1.1M position · as of 2026-07-31
3.4%
First Trust Consumer Discretionary AlphaDEX Fund
$4.5M position · as of 2026-07-31
1.7%
Inspire Growth ETF
$2.5M position · as of 2026-05-31
1.5%
PIMCO RAE US Small Fund
$55.5M position · as of 2026-06-30
1.5%
State Street(R) SPDR(R) S&P(R) Retail ETF
$4.7M position · as of 2026-06-30
1.2%
Cambria Shareholder Yield ETF
$9.7M position · as of 2026-07-31
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · William Dillard, II
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$4.9M
$5.7M
$3.3M
+866%
+84%
2023
$12.5M
$6.3M
$5.8M
+661%
+49%
2022
$22.6M
$7.9M
$10.1M
+600%
+29%
2021
$12.7M
$12.8M
$6.4M
+340%
+17%
2020
$2.9M
$1.7M
$1.9M
+47%
+7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $243.7K sold by insiders over 180 days, 177 funds added last quarter. Each figure is a federal filing, dated the day it went public.
DDS financials
Revenue growth
-0.1%
XBRL, annual
Net margin
8.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.6B
four quarters, 2025-08-03 to 2026-08-01
Revenue, TTM DDS
| FY Jan 2026 | $6.6B |
| FY Feb 2025 | $6.6B |
| FY Feb 2024 | $6.9B |
| FY Jan 2023 | $7.0B |
| FY Jan 2022 | $6.6B |
| Aug 2026 | $1.5B |
| May 2026 | $1.6B |
| Jan 2026 | $2.0B |
| Nov 2025 | $1.5B |
| Aug 2025 | $1.5B |
| May 2025 | $1.5B |
| Feb 2025 | $2.1B |
| Nov 2024 | $1.5B |
At each fiscal year end
Single quarter
Net margin, TTM
+10.3%
net income over revenue, 2025-08-03 to 2026-08-01
Net margin, TTM DDS
| FY Jan 2026 | +8.7% |
| FY Feb 2025 | +9.0% |
| FY Feb 2024 | +10.7% |
| FY Jan 2023 | +12.7% |
| FY Jan 2022 | +13.0% |
| Aug 2026 | +6.4% |
| May 2026 | +15.8% |
| Jan 2026 | +10.2% |
| Nov 2025 | +8.7% |
| Aug 2025 | +4.7% |
| May 2025 | +10.6% |
| Feb 2025 | +10.4% |
| Nov 2024 | +8.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$635.1M
operating cash flow minus capex, 2025-08-03 to 2026-08-01
Free cash flow, TTM DDS
| FY Jan 2026 | $623.6M |
| FY Feb 2025 | $609.6M |
| FY Feb 2024 | $750.6M |
| FY Jan 2023 | $828.3M |
| FY Jan 2022 | $1.2B |
| Aug 2026 | -$59.5M |
| May 2026 | $346.8M |
| Jan 2026 | $191.6M |
| Nov 2025 | $156.2M |
| Aug 2025 | $60.1M |
| May 2025 | $215.8M |
| Feb 2025 | $349.3M |
| Nov 2024 | $145.4M |
At each fiscal year end
Single quarter
Debt to equity
0.07x
long-term 2026-08-01 plus current 2019-05-04 (88 months older than the period end); equity 2026-08-01
Debt to equity DDS
| FY Jan 2026 | 0.13x |
| FY Feb 2025 | 0.18x |
| FY Feb 2024 | 0.19x |
| FY Jan 2023 | 0.20x |
| FY Jan 2022 | 0.22x |
| Aug 2026 | 0.07x |
| May 2026 | 0.11x |
| Jan 2026 | 0.13x |
| Nov 2025 | 0.11x |
| Aug 2025 | 0.12x |
| May 2025 | 0.17x |
| Feb 2025 | 0.18x |
| Nov 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
4.97x
TTM operating cash flow over long-term 2026-08-01 plus current 2019-05-04 (88 months older than the period end)
Cash flow to debt DDS
| FY Jan 2026 | 3.18x |
| FY Feb 2025 | 2.22x |
| FY Feb 2024 | 2.75x |
| FY Jan 2023 | 2.95x |
| FY Jan 2022 | 3.98x |
| Aug 2026 | 4.97x |
| May 2026 | 3.76x |
| Jan 2026 | 3.18x |
| Nov 2025 | 3.86x |
| Aug 2025 | 3.80x |
| May 2025 | 2.18x |
| Feb 2025 | 2.22x |
| Nov 2024 | 2.44x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+33.8%
TTM net income over average of 2025-08-02 and 2026-08-01
Return on equity DDS
| FY Jan 2026 | +31.9% |
| FY Feb 2025 | +34.0% |
| FY Feb 2024 | +44.8% |
| FY Jan 2023 | +58.5% |
| FY Jan 2022 | +59.6% |
| Aug 2026 | +33.8% |
| May 2026 | +33.8% |
| Jan 2026 | +31.9% |
| Nov 2025 | +29.0% |
| Aug 2025 | +29.8% |
| May 2025 | +30.9% |
| Feb 2025 | +34.0% |
| Nov 2024 | +33.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+18.3%
TTM net income over average of 2025-08-02 and 2026-08-01
Return on assets DDS
| FY Jan 2026 | +16.2% |
| FY Feb 2025 | +17.0% |
| FY Feb 2024 | +21.8% |
| FY Jan 2023 | +27.1% |
| FY Jan 2022 | +27.2% |
| Aug 2026 | +18.3% |
| May 2026 | +16.3% |
| Jan 2026 | +16.2% |
| Nov 2025 | +13.8% |
| Aug 2025 | +15.7% |
| May 2025 | +14.7% |
| Feb 2025 | +17.0% |
| Nov 2024 | +15.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital DDS
| FY Jan 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Jan 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed DDS
| FY Jan 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Jan 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
15.94x
close 2026-10-23 over four quarters of diluted EPS, 2025-08-03 to 2026-08-01
P/E, trailing DDS
| FY Jan 2026 | 16.70x |
| FY Feb 2025 | 12.72x |
| FY Feb 2024 | 8.77x |
| FY Jan 2023 | 7.49x |
| FY Jan 2022 | 5.98x |
| Aug 2026 | 13.48x |
| May 2026 | 13.45x |
| Jan 2026 | 16.70x |
| Nov 2025 | 16.32x |
| Aug 2025 | 12.95x |
| May 2025 | 10.06x |
| Feb 2025 | 12.72x |
| Nov 2024 | 9.55x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value DDS
| FY Jan 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Jan 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield DDS
| FY Jan 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Jan 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.77x
P/E over trailing EPS growth of 21%: four quarters to 2026-08-01 against the four to 2025-08-02
PEG, trailing DDS
| FY Jan 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Jan 2023 | 0.36x |
| FY Jan 2022 | n/a |
| Aug 2026 | 0.65x |
| May 2026 | 0.82x |
| Jan 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-01 | 2025-02 | 2024-02 | 2023-01 | |
|---|---|---|---|---|
| Revenue | $6.6B | $6.6B | $6.9B | $7.0B |
| Gross profit | $2.6B | $2.6B | $2.7B | $2.9B |
| Net income | $570.2M | $593.5M | $738.8M | $891.6M |
| EPS (diluted) | 36.42 | 36.82 | 44.73 | 50.81 |
| Operating cash flow | $717.0M | $714.1M | $883.6M | $948.4M |
| Cash | $861.5M | $717.9M | $808.3M | $650.3M |
| Long-term debt | $225.7M | $321.6M | $321.5M | $321.4M |
| Buybacks | $107.8M | $121.0M | $281.4M | $452.9M |
| Dividends paid | $484.9M | $413.8M | $338.6M | $271.3M |
SEC XBRL, fiscal years, as known on 2026-10-27
DDS Stock Sonar score 6/7 axes
Find similar shapesCompareDDS ranks highest on profitability (91st percentile) and financial health (84th), and lowest on insider conviction (31st), among Wholesale & Retail peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DDS filings, in plain words
Are Dillard's insiders buying or selling DDS?
In the 180 days to 2026-10-27, Dillard's insiders were net sellers, a net $243.7K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-27, Dillard's insiders were net sellers of DDS, a net $243.7K across purchases and sales reported on Form 4 by 1 seller. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 31.8% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
